In-vitro equivalence [General Sta­tis­tics]

posted by martin  – Austria, 2012-05-19 12:28 (5140 d 16:31 ago) – Posting: # 8589
Views: 6,107

Dear ElMaestro!

We were asked by a regulator to examine a random sample of k>25 lots produced (including also already formally "released" lots) each evaluated with at least 3 replicates. The information that I have is that we have to show (whatever that means) that the lots are "comparable" to the reference lot (i.e. kind of standard) and superior to the negative control lot (also a kind of standard without biological activity).

I would be really glad to get some ideas and suggestions!

best regards

martin

PS.: I do not like the word comparable: apple and oranges

PPS.: it's a biologic - QbD :smoke:

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
151 visitors (0 registered, 151 guests [including 20 identified bots]).
Forum time: 05:00 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5